FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - ValueSet

29,056 resources

Type: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 14800 - 15000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuth
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.7.16--20171231000000IngredientCodeGTINCodelijstactivenlhl7
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.11.1.5--20171231000000ProductCodeGTINCodelijstactivenlhl7
kbv.ita.awsR4ValueSet/KBV_VS_AW_Anlage_IdentifiertypKBV_VS_AW_Anlage_Identifiertypactive2020-02
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7726Glove Material (RIBD)active2018-01us
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.53.11.1--20200618120422GlucoseMeetmomentenLOINCCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.53.11.2--20190813000000GlucoseMeetmomentenNhgtable45Codelijstactivenl
hl7.fhir.dk.kl.gateway.careR4ValueSet/FSIIICareGoalTypesFSIIICareGoalTypesactive2021-02dkhl7
kl.dk.fhir.gatewayR4ValueSet/FSIIICareGoalTypesFSIIICareGoalTypesactive2024-10dk
hl7.fhir.be.pssR4ValueSet/GonokokCodesGonokok Codesactive2025-07behl7
dk.kip.rkkp.fhir.ig.coreR4ValueSet/GradAkutDHDBGrad af akut (DHDB)active2024-09
silfhirprofileigR5ValueSet/sghi-gradeGrade Value Setsactive2025-07
hl7.eu.fhir.pcspR4ValueSet/grade-test-vsGrade: follow updraft2025-08euhl7
dk.kip.rkkp.fhir.ig.coreR4ValueSet/AnurismeAflukningGraden af aflukning af anurismeactive2022-06
dk.kip.rkkp.fhir.ig.coreR4ValueSet/ResttumorGraderingGraderingactive2022-06
de.dktk.oncologyR4ValueSet/ValueSet-onco-core-ValueSet-GradingVSGradingVSactive
cce.fhir.minimalR4ValueSet/ValueSet-cce-core-ValueSet-GradingVSGrading VSdraft
dk.kip.rkkp.fhir.ig.coreR4ValueSet/GraftDKRRGraft (DKRR)active2022-09
dk.kip.rkkp.fhir.ig.coreR4ValueSet/GraftACLDKRRGraft, ACL (DKRR)active2022-09
healthdata.be.r4.cbbR4ValueSet/GrimaceScoreGrimaceScoredraft
nictiz.fhir.nl.stu3.geboortezorgR3ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.37--20141020151252Groei afwijkendactivenl
healthdata.be.r4.cbbR4ValueSet/GroomingGroomingdraft
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1248.179Intubationactive2022-07ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.11Estrogen Receptor Test for Orserduactive2023-08ushl7
smart.who.int.ancR4ValueSet/anc-b8-de71-choices-grouperAbdominal exam result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b8-de61-choices-grouperBreast exam result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b8-de50-choices-grouperCardiac exam result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de146-choices-grouperCurrent alcohol and/or other substance use Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de109-choices-grouperCurrent medications Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b7-de43-choices-grouperCurrent physiological symptoms Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de139-choices-grouperDaily caffeine intake Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b5-de48-choices-grouperDanger signs Choices Grouperdraft2021-09uvwho
hl7.fhir.uv.cqlR4ValueSet/publishable-exampleExample Danger signs Codes Grouperdraft2023-07uvhl7
hl7.fhir.uv.crmiR4ValueSet/computable-exampleDanger signs Codes Grouper (Computable Example)draft2023-07uvhl7
hl7.fhir.uv.crmiR4ValueSet/expanded-exampleDanger signs Codes Grouper (Expanded Example)draft2023-07uvhl7
hl7.fhir.uv.crmiR4ValueSet/publishable-exampleDanger signs Codes Grouper (Publishable Example)draft2023-07uvhl7
smart.who.int.ancR4ValueSet/anc-b9-de172-choices-grouperDiabetes mellitus (DM) during pregnancy diagnosis Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de83-choices-grouperExisting chronic health conditions Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b10-de145-choices-grouperFamily planning method selected Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b8-de111-choices-grouperFetal presentation Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de105-choices-grouperFlu immunization history Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de169-choices-grouperGestational diabetes mellitus (GDM) diagnosis Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de45-choices-grouperHIV status Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de41-choices-grouperHIV test result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de74-choices-grouperHepatitis B diagnosis Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de66-choices-grouperHepatitis B test result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de92-choices-grouperHepatitis C diagnosis Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de89-choices-grouperHepatitis C test result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b7-de1-choices-grouperMedication follow-up Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de129-choices-grouperMidstream urine Gram-staining Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de124-choices-grouperMidstream urine culture (recommended) Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de7-choices-grouperOccupation Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de55-choices-grouperPartner HIV status (confirmed) Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de156-choices-grouperPartner HIV status (reported) Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de48-choices-grouperPartner HIV test result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de34-choices-grouperPast pregnancy complications Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b8-de79-choices-grouperPelvic exam result (visual) Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b7-ded9-choices-grouperPersistent behaviours Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b7-de18-choices-grouperPersistent physiological symptoms Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b10-de137-choices-grouperPlanned birth place Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b7-de71-choices-grouperPresenting signs and symptoms that trigger suspicion of IPV and clinical inquiry Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b5-de1-choices-grouperReason for coming to facility Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b8-de39-choices-grouperRespiratory exam result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de29-choices-grouperRh factor Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b8-de27-choices-grouperSymptoms of severe pre-eclampsia Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de110-choices-grouperSyphilis diagnosis Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de107-choices-grouperSyphilis test result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de98-choices-grouperSyphilis test type Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de206-choices-grouperTB screening result Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b6-de100-choices-grouperTetanus toxoid-containing vaccine (TTCV) immunization history Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de150-choices-grouperUrine dipstick result - glucose Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de138-choices-grouperUrine dipstick result - leukocytes Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de132-choices-grouperUrine dipstick result - nitrites Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b9-de144-choices-grouperUrine dipstick result - protein Choices Grouperdraft2021-09uvwho
smart.who.int.ancR4ValueSet/anc-b8-de5-choices-grouperWeight category Choices Grouperdraft2021-09uvwho
fhir.outburn.co.ilR4ValueSet/observation-group-codeObservation Group Codedraftushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.13HER2 Negativeactive2023-09ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1099.57Advance Directives Content Typeactive2025-03ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.974MASLDactive2025-02ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.17Metastatic Breast Canceractive2023-09ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1130.12Toxic Megacolon in adultsactive2019-04ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.267CDS Rhabdomyolysisactive2024-06ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1121.5Most/Moderately Effective Contraceptive Proceduresactive2024-06ushl7
caseworks.mhaie002R4ValueSet/vs-AssociationTypesAssociationTypesValueSetactive
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.226Systolic Heart Failureactive2025-03ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.572Allergy to house dust mitesactive2023-08ushl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.622relatedconditions_Asthmaactive2023-09ushl7
de.gevko.evo.khbR4ValueSet/EVO_VS_KB_BefoerderungsgrundGrund der Beförderungactive2020-06
de.gevko.eahbR4ValueSet/EAHBVSBeitraegeRentenversicherungGrundGrund für Beiträge zur Rentenversicherung oder zur Alterssicherungactive2021-04
dk.kip.rkkp.fhir.ig.coreR4ValueSet/GrundlidelseDKRGrundlidelse (DKR)active2022-10
dk.kip.rkkp.fhir.ig.coreR4ValueSet/GrundlidelseDSRGrundlidelse (DSR)active2022-10
dk.kip.rkkp.fhir.ig.coreR4ValueSet/GrundlidelseDHRGrundlidelse [DHR]active2022-07
br.go.ses.coreR4ValueSet/subgrupo-0202-tabela-statusSubgrupo 0202 da Tabela SUSactive2025-01br
br.gov.saude.ccuR4ValueSet/resultados-itensComponentes de resultado de examedraft2024-07br
kbv.mio.u-heftR4ValueSet/KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_ReasonGründe zur Ablehnung des Pulsoxymetriescreeningsactive
hl7.terminologyR5ValueSet/v3-RoleClassGuardianRoleClassGuardianactive2014-03uvhl7
kl.dk.fhir.ffbmessagingR4ValueSet/kl-messaging-ffb-guardianshipFormValuesGuardianshipFormsactive2023-08dk
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-type-eu-pcspGvhd conditiondraft2025-08euhl7
nictiz.fhir.nl.stu3.geboortezorgR3ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.16--20140814134544Gynaecologische aandoeningenactivenl
dk.kip.rkkp.fhir.ig.coreR4ValueSet/GynUndersoegDUGAGynækologisk undersøgelsesmetode (DUGA)active2024-02
br.gov.saude.ccuR4ValueSet/generosGênerosactive2024-07br
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7741H Antigens (FDD)active2018-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7809H. influenzae Serotype (RIBD)active2018-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8061HBV DNA Test Result (Hepatitis B Perinatal)active2022-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8043HBeAg Test Result (Hepatitis B Perinatal)active2021-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8056HBsAg Test Result (Hepatitis B Perinatal)active2021-01us
nictiz.fhir.nl.stu3.zib2020-preadoptR3ValueSet/zib-LegalSituation-ValueSetsHCIM LegalSitation ValueSetsactivenl
hl7.fhir.us.davinci-vbprR4ValueSet/hcplan-frameworkHCPLAN Framework Categoriestrial-use1cqi2025-07ushl7
ch.fhir.ig.ch-termR4ValueSet/HCProfessional.hcProfessionHCProfessional.hcProfessionactive2025-05chhl7
ch.fhir.ig.ch-epr-termR4ValueSet/HCProfessional.hcProfessionHCProfessional.hcProfessionactive2023-12chhl7
ch.fhir.ig.ch-termR4ValueSet/HCProfessional.hcSpecialisationHCProfessional.hcSpecialisationactive2025-05chhl7
ch.fhir.ig.ch-epr-termR4ValueSet/HCProfessional.hcSpecialisationHCProfessional.hcSpecialisationactive2023-12chhl7
healthdata.be.r4.dcdR4ValueSet/HDBP0037-ResultFlagsHDBP0037-ResultFlagsdraft
hl7.fhir.cz.hdrR4ValueSet/exposureAgent-eu-hdrExposure of transmissible agentsdraft12025-08czhl7
hl7.fhir.eu.hdrR4ValueSet/exposureAgent-eu-hdrExposure of transmissible agentsdraft12025-06euhl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.32HER2 Positiveactive2023-09ushl7
hl7.fhir.uv.genomics-reportingR4ValueSet/hgvs-vsHuman Genome Variation Society (HGVS) Nomenclaturetrial-use2cg2025-06uvhl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3369Route Of Administration (IIS)active2018-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3232HIV Status (PHCR)active2009-01us
de.geccoR4ValueSet/1.2.276.0.76.11.530--20200709125648Human Immunodeficiency Virus Infectionsactive
de.geccoR4ValueSet/2.16.840.1.113883.3.1937.99.61.65.11.4--20200709152345Human Immunodeficiency Virus Infections ICD-10-GMactive
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7192HIV Status (STD)active2019-12us
ihe.iti.pcfR4ValueSet/SlsSensitiveHIVclinical codes that indicate HIVdraft2024-10uvihe
hl7.terminologyR5ValueSet/v2-0357hl7VS-messageErrorConditionCodesactive2019-12uvhl7
hl7.terminologyR5ValueSet/standards-statusStandardsStatusdraftfhir2020-02uvhl7
hl7.fhir.eu.imaging-manifest-r5R5ValueSet/ImImagingManifestTypesEuVSHL7 EU Imaging Manifest Typesdraft2025-07euhl7
hl7.fhir.eu.imaging-r5R5ValueSet/ImImagingManifestTypesEuVSHL7 EU Imaging Manifest Typesdraft2025-08euhl7
hl7.fhir.eu.imaging-manifest-r5R5ValueSet/ImImagingReportTypesEuVSHL7 EU Imaging Report Typesdraft2025-07euhl7
hl7.fhir.eu.imaging-r5R5ValueSet/ImImagingReportTypesEuVSHL7 EU Imaging Report Typesdraft2025-08euhl7
hl7.fhir.uv.ipsR4ValueSet/current-smoking-status-uv-ipsCurrent Smoking Status - IPStrial-use2pc2025-08uvhl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7256Morphologic Abnormalities of Neoplasmsdraftus
de.gematik.isikR4ValueSet/current-smoking-status-uv-ipsCurrent Smoking Status - IPSactivedehl7
tw.gov.mohw.twcoreR4ValueSet/v3-orderableDrugFormHL7 OrderableDrugForm藥品劑型值集active2019-03twnational
tw.gov.mohw.twcoreR4ValueSet/provenance-participant-type-hl7-twHL7 Provenance participant type + 臺灣衛福部資訊處Provenance參與類型active2024-08twnational
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.809Marital Status (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1017Nature of Abnormal Test (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3338Coding System HL7 2x Table 0396active2021-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.820Expanded Yes No (HL7)active2008-01us
tw.gov.mohw.nhi.pasR4ValueSet/medication-frequency-hl7-nhiHL7 TimingAbbreviation + NHI-健保事前審查-藥品使用頻率值集active2024-01twnational
tw.gov.mohw.twcoreR4ValueSet/medication-frequency-hl7-twHL7 TimingAbbreviation + 臺灣健保署藥品使用頻率值集active2024-01twnational
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.875Null Flavor (HL7 V3)active2008-01us
hl7.fhir.us.vitalsignsR4ValueSet/abnIntNumericNomVSAbnormal Interpretation Numeric Nominal value setdraft2015-04ushl7
hl7.terminologyR5ValueSet/v2-0354hl7VS-messageStructureactive2019-12uvhl7
hl7.terminologyR5ValueSet/v3-HL7ITSVersionCodeHL7ITSVersionCodeactive2014-03uvhl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1028Processing ID (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1059Value Type (HL7)active2015-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.810Name Type (HL7)active2011-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.818Telecommunication Use Code (HL7)active2018-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.817Telecommunication Equipment Type (HL7)active2018-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1029Processing Mode (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1055Universal ID Type (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.925Pharmacy Order Type (HL7)active2008-01us
hl7.v2plusR5ValueSet/complex-data-typesHL7 v2 Complex Data Types ValueSettrial-useinm2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3014Source of Comment (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.802Administration Device (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.803Administration Method (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.961Address Typeactive2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.960Specimen Additive or Preservative (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.927Administrative Sex (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.913Admission Type (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.800Abnormal Flag (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.806Allergen Type (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.807Allergy Severity (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.912Admission Level of Care (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3350Alternate Character Set Handling Scheme (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3347Alternate Character Sets (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3355Authorization Mode (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3339Check Digit Scheme (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3337Event Type (HL7)active2018-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3349Message Structure (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3341Message Type (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3351Name Assembly Order (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3352Name Address Representation (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3354Order Type (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3346Organizational Name Type (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3021Preferred Method of Contact (HL7)active2008-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3356Risk Codes (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3340Specimen Action Code (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3353TQ Conjunction ID (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3345Type of Referenced Data (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3348Visit Indicator (HL7)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3362Event Type (IIS)active2018-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3364Message Type (IIS)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3367Version ID (IIS)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3368Order Control Code (IIS)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3383Quantity Limited Request (IIS)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3370Administrative Site (IIS)active2019-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3371Name Type (IIS)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6063Universal ID Type (IIS)active2012-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3375Action Code (IIS)active2010-01us
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3376Message Structure (IIS)active2010-01us
poc.bonsai.currentR4ValueSet/nll-event-timingPeriod på dygnetactive2021-11
poc.bonsai.currentR4ValueSet/nll-concept-map-equivalenceEkvivalensactive2021-11
tw.gov.mohw.nhi.ciR4ValueSet/media-mimetypesHL7-健保重大傷病-非DICOM影像MimeType值集active2025-04twnational
tw.gov.mohw.nhi.pasR4ValueSet/media-mimetypesHL7-非DICOM影像MimeType值集active2025-07twnational
tw.gov.mohw.twcoreR4ValueSet/media-mimetypesHL7-非DICOM影像MimeType值集active2024-12twnational
uk.nhsdigital.r4.testR4ValueSet/v2-hscic-0200-NameTypeHL7v2HSCICTable0200Nametypeactivehl7
uk.nhsdigital.r4.testR4ValueSet/v3-npfit-nameuse-vsHL7v3NPfITNameUseactivehl7
jp-core.r4R4ValueSet/jp-medication-route-hl70162-vsJP Core Medication HL70162-based Route ValueSetactive2022-10jp
hla.antibody.reportR4ValueSet/Hla_immunoassay_bead_control_type_vsHLA Immunoassay Bead Control Type Value Setdraft
hla.antibody.reportR4ValueSet/Hla_immunoassay_bead_observation_classification_vsHLA Immunoassay Bead Observation Classification Value Setdraft